Role of the EGFR mutations in lung cancer has been described in previous studies.8,34,35 EGFR mutations treated with EGFR-TKI-targeted therapy showed a significantly improved survival rate with lung adenocarcinoma.7,35,36 However, the multiple mutations are not completely understood. This evidence concerns the gene EGFR and lung adenocarcinoma.